戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ease 11 L/min and 8 L/min) than those taking terbutaline.
2 RV observed between sexes were attenuated by terbutaline.
3 e randomly assigned formoterol 4.5 microg or terbutaline 0.5 mg as needed by Turbuhaler in daily dose
4 5 microg provided better asthma control than terbutaline 0.5 mg in patients requiring moderate doses
5 horbol 12-myristate 13-acetate (PMA, 10 nM), terbutaline (0.1 mM), or ATP (1 mM), the binding of SP-A
6                                              Terbutaline (0.2-0.3 mg/kg) was administered orally at 2
7 voked NO release (isoproterenol; dobutamine; terbutaline; 10(-9) to 10(-5) m) was blocked by the NOS
8 ol eyes spiked with salbutamol (100 ppb) and terbutaline (25-100 ppb).
9                                              Terbutaline (a selective beta(2)AR agonist) and ICI 118,
10                                              Terbutaline, a beta2-adrenergic receptor (beta2-AR) agon
11 R responses in newborn rats, we administered terbutaline, a beta2AR agonist, on postnatal day 2 and e
12 ted with cAMP or the beta-adrenergic agonist terbutaline, a biphasic AQP5 response was observed.
13 ) M), the putative beta 2-adrenergic agonist terbutaline also caused preconstricted arterioles and ve
14 DNN), were compared pre-terbutaline and post-terbutaline and across phenotype, genotype and sex.
15 rmal R-R intervals (SDNN), were compared pre-terbutaline and post-terbutaline and across phenotype, g
16                                 A regimen of terbutaline and theophylline seems to be effective proph
17                                              Terbutaline at 10(-6) mol/l stimulated glycerol release
18 h2 cells were exposed to the beta2AR agonist terbutaline before activation by Ag-presenting B cells.
19 usside (endothelium independent agonist) and terbutaline (beta(2)-adrenergic receptor agonist) with a
20                               Dobutamine and terbutaline, beta1- and beta2-adrenoceptor agonists, evo
21 erol, and is metabolized (bioconverted) into terbutaline by butyrylcholinesterase (BChE).
22 d for the enantiomeric separation of racemic terbutaline by capillary electrophoresis.
23 re isometric tension after administration of terbutaline (concentration range, 10(-8) to 10(-4) M), d
24                    In contrast to Th1 cells, terbutaline did not affect either IL-4 production by Th2
25  to determine whether other bronchodilators (terbutaline, diltiazem, and aminophylline) relax bronchi
26 nding sites and expectedly right-shifted the terbutaline dose-response curve to 8 +/- 3 microM.
27              Epinephrine was not required at terbutaline doses of >2 microg/kg/min.
28 acting beta-agonist formoterol compared with terbutaline, each taken as needed, in patients with mode
29 rnatants, the lower level of IL-2 present in terbutaline-exposed culture supernatants supported the p
30                                              Terbutaline exposure of Th1 cells before activation inhi
31 approved drugs and natural products, such as terbutaline, fenoterol, resveratrol, and catechin.
32               When Th clones were exposed to terbutaline following anti-CD3 activation, Th1 cell, but
33 pre-exposed to Ag and/or the beta 2AR ligand terbutaline for 24 h before being activated by either a
34     The antagonist propranolol competed with terbutaline for beta2AR binding sites and expectedly rig
35 ry response to ACh, sodium nitroprusside and terbutaline in young premenopausal (all P < 0.05) but no
36           beta2AR agonists isoproterenol and terbutaline increased basal AC activity with EC50s of 2.
37 acellular cAMP were similar in both subsets, terbutaline induced an increase in cAMP levels in Th1 ce
38 ntagonist atenolol (10(-6) M) did not affect terbutaline-induced dilation in preconstricted arteriole
39 beta2-adrenergic stimulation was produced by terbutaline infusion in three additional baboons.
40  azathioprine, ciclosporin, and subcutaneous terbutaline infusions.
41 ist, butoxamine, suggests that the effect of terbutaline is mediated by activation of beta2-adrenergi
42 hese structurally related bronchodilators is terbutaline; it is administered as a prodrug, bambuterol
43 > .05) was the most efficacious, followed by terbutaline (maximum relaxation, 72%+/-13% [proximal], 5
44 2)-adrenergic receptor ligands (epinephrine, terbutaline, metaproterenol, salmeterol, propranolol, al
45                      Pups were injected with terbutaline on postnatal days 2-5.
46 e magnitude of CPK-MB concentrations and the terbutaline or epinephrine doses used.
47 hythmias were rare and not related to either terbutaline or epinephrine doses.
48 ells to either the beta 2AR-selective ligand terbutaline or the sympathetic neurotransmitter norepine
49 ean heart rate was significantly higher post-terbutaline (p < 0.0001).
50                                         Oral terbutaline plus aminophylline or theophylline.
51                  The beta-adrenergic agonist terbutaline produced changes in AQP5 abundance in mouse
52 ing beta2-agonists albuterol, fenoterol, and terbutaline provide rapid as-needed symptom relief and s
53                                     However, terbutaline relaxed the distal airway more than the prox
54                    Either maternal stress or terbutaline resulted in autistic-like behaviors in offsp
55                           HRV decreased post-terbutaline (SDNN: p = 0.0008) and changes in HRV observ
56  of dobutamine (selective beta1-agonist) and terbutaline (selective beta2-agonist) on glycerol releas
57            The results demonstrate that only terbutaline showed a differential airway relaxant effect
58                                              Terbutaline significantly lowered DBP when used between
59 ntratracheal PBS than normal lungs following terbutaline stimulation ex vivo.
60 vivo tests using zebrafish models found that terbutaline sulfate prevents defects in axons and neurom
61                   A therapeutic potential of terbutaline sulfate was also observed when axonal and ne
62  Interestingly, the prediction suggests that terbutaline sulfate, which is widely used for asthma, is
63                                              Terbutaline (TERB) and isoproterenol (ISO) increased lun
64  influence the SVR response to ADRB2 agonist terbutaline (Terb) during ganglionic blockade.
65 ) responses to administration of intravenous terbutaline (TRB) before and after 5 days of low dietary
66                                              Terbutaline treatment attenuated the VWR-mediated protec
67  and combined effects of maternal stress and terbutaline (used to arrest preterm labor), autism risk
68 chiral separation of milligram quantities of terbutaline using sulfated cyclodextrin as a chiral addi
69                                    In women, terbutaline was more effective in lean than in obese wom
70                                  Intravenous terbutaline was well tolerated in asthmatic children for
71 aline and adrenaline than when salbutamol or terbutaline were present (e.g., log KD propranolol -8.65
72 d of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP produc
73 atients may be treated with theophylline and terbutaline, which clinical experience suggests may redu
74 during variations in the dose of intravenous terbutaline, with or without epinephrine.
75  epinephrine > or = formoterol = fenoterol > terbutaline = zinterol = albuterol > salmeterol > dobuta